Staar Surgical Co (STAA)
37.23
+3.36
(+9.92%)
USD |
NASDAQ |
Sep 27, 16:00
37.84
+0.61
(+1.64%)
After-Hours: 20:00
Staar Surgical Research and Development Expense (TTM): 49.77M for June 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | 49.77M |
| March 31, 2024 | 47.47M |
| December 31, 2023 | 44.40M |
| September 30, 2023 | 43.32M |
| June 30, 2023 | 41.47M |
| March 31, 2023 | 38.35M |
| December 31, 2022 | 35.98M |
| September 30, 2022 | 35.26M |
| June 30, 2022 | 33.92M |
| March 31, 2022 | 33.54M |
| December 31, 2021 | 33.86M |
| September 30, 2021 | 33.75M |
| June 30, 2021 | 34.23M |
| March 31, 2021 | 33.28M |
| December 31, 2020 | 31.92M |
| September 30, 2020 | 30.37M |
| June 30, 2020 | 27.77M |
| March 31, 2020 | 26.56M |
| December 31, 2019 | 25.30M |
| September 30, 2019 | 23.59M |
| June 30, 2019 | 23.01M |
| March 31, 2019 | 22.26M |
| December 31, 2018 | 22.03M |
| September 30, 2018 | 21.95M |
| June 30, 2018 | 20.97M |
| Date | Value |
|---|---|
| March 31, 2018 | 20.39M |
| December 31, 2017 | 19.77M |
| September 30, 2017 | 18.79M |
| June 30, 2017 | 18.65M |
| March 31, 2017 | 18.54M |
| December 31, 2016 | 20.67M |
| September 30, 2016 | 19.98M |
| June 30, 2016 | 19.21M |
| March 31, 2016 | 18.09M |
| December 31, 2015 | 14.76M |
| September 30, 2015 | 16.44M |
| June 30, 2015 | 15.90M |
| March 31, 2015 | 14.86M |
| December 31, 2014 | 14.76M |
| September 30, 2014 | 11.09M |
| June 30, 2014 | 9.638M |
| March 31, 2014 | 8.826M |
| December 31, 2013 | 6.708M |
| September 30, 2013 | 6.54M |
| June 30, 2013 | 6.438M |
| March 31, 2013 | 6.265M |
| December 31, 2012 | 6.445M |
| September 30, 2012 | 6.23M |
| June 30, 2012 | 6.102M |
| March 31, 2012 | 5.982M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
23.59M
Minimum
Sep 2019
49.77M
Maximum
Jun 2024
35.21M
Average
33.89M
Median
Research and Development Expense (TTM) Benchmarks
| The Cooper Companies Inc | 154.10M |
| OrthoPediatrics Corp | 10.68M |
| NexGel Inc | 0.097M |
| Innovative Eyewear Inc | 0.7866M |
| Abbott Laboratories | 2.754B |